FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions refers to medicine, more specifically to oncology and concerns using neranitib and capecitabine in a combination for treating a new growth (breast cancer); wherein neranitib is administered in the approximate amount of 240 mg a day, and capecitabine is administered in the approximate amount of 1500 mg a day. There are also presented: a pharmaceutical composition, a kit and a method of treating breast cancer which involves administering neranitib and capecitabine.
EFFECT: group of inventions provides a synergetic effect of administering neranitib in the approximate amount of 240 mg a day and capecitabine in the approximate amount of 1500 mg a day in a combination for treating new growths.
19 cl, 2 tbl, 4 ex
